Vascular Biogenics Ltd (VBLT)

[davidal66]

VBLT manufactured VB111 and has a site where the drug was distributed for the trial. They don't know names, but they may that study number 15 was recruited on November 13 , 2016 and got VB111. Do they know that level of granularity. I think they do, but, of course, I cannot prove it. Open label trials like this tend to diffuse/bleed data out... not right away, but on the big picture, yes. I think by communicating with docs in the trial about their impressions, their knowledge of total study drug given in total over the GLOBE trial, with their knowledge of recruitment rates(they know the exact median/mean date of entrants, combined with their knowledge of death rates(at what time have 25, 50 % of deaths occurred), they can then backtrack and probably have a very good estimate about how the trial is doing. Not exact science, but pretty good.